What are the principles of dual antiplatelet therapy for cerebral infarction?
Generally, the principles of dual antiplatelet therapy for cerebral infarction include timely treatment, individualized treatment, and medication use according to medical advice. The details are as follows:
1. Timely Treatment
Cerebral infarction refers to insufficient blood supply to the brain caused by blockage of cerebral blood vessels, leading to brain tissue hypoxia, ischemia, and necrosis. There are many treatment methods available for cerebral infarction, among which dual antiplatelet therapy is currently a commonly used approach. The time window for treating cerebral infarction is critically important; therefore, dual antiplatelet therapy should be initiated as early as possible. Typically, the optimal therapeutic effect is achieved when treatment begins within 4.5 hours after the onset of cerebral infarction.
2. Individualized Treatment
Treatment for cerebral infarction should be tailored according to each patient's specific condition, and dual antiplatelet therapy is no exception. Doctors need to consider factors such as the patient’s age, underlying diseases, and severity of illness to develop an individualized treatment plan.
3. Medication Use According to Medical Advice
Dual antiplatelet therapy usually refers to the combined use of tissue-type plasminogen activator and mechanical thrombectomy. In some cases, using either method alone may not achieve the desired therapeutic effect, thus combination therapy is required. Commonly used medications in dual antiplatelet therapy include enteric-coated aspirin tablets and clopidogrel hydrogen sulfate tablets.
It should be noted that dual antiplatelet therapy for cerebral infarction must be conducted under the guidance of a qualified physician.